Michael Torbenson
0000-0002-8334-7725
Publication & Citation Trends
Publications
0 total
Clinical guideline for the diagnosis and treatment of fibrolamellar carcinoma.
Cited by 0
Semantic Scholar
Abstract 2611: Prospective evaluation of 68Ga-PSMA PET imaging in advanced hepatocellular carcinoma patients undergoing first line immunotherapy.
Cited by 0
Semantic Scholar
First-line atezolizumab/bevacizumab or durvalumab/tremelimumab in advanced hepatocellular carcinoma: a real world, multicenter retrospective study
Cited by 2
Semantic Scholar
PTEN Deficiency Induces an Extrahepatic Cholangitis-Cholangiocarcinoma Continuum via Aurora kinase A in Mice.
Cited by 12
Semantic Scholar
Immunohistochemical basis for FAP as a candidate theranostic target across a broad range of cholangiocarcinoma subtypes OA
Cited by 6
Semantic Scholar
Liver cancer multiomics reveals diverse protein kinase A disruptions convergently produce fibrolamellar hepatocellular carcinoma
Cited by 7
Semantic Scholar
Abstract B022: Precision medicine for the fusion protein driven cancer, fibrolamellar carcinoma (FLC): Beyond sequencing
Cited by 0
Semantic Scholar
Prognostication of ß-catenin (CTNNB1) in patients with HCC treated with first line immunotherapy.
Cited by 3
Semantic Scholar
Research Topics
Liver Disease Diagnosis and Treatment
(115)
Hepatocellular Carcinoma Treatment and Prognosis
(88)
Cholangiocarcinoma and Gallbladder Cancer Studies
(53)
Cancer Genomics and Diagnostics
(52)
Hepatitis C virus research
(49)
Affiliations
James S. McDonnell Foundation
University of Verona
University of Maryland, Baltimore
Cedars-Sinai Medical Center
Roswell Park Comprehensive Cancer Center